CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a novel therapeutic strategy for pulmonary fibrosis by targeting a specific protein interaction that drives the disease. By disrupting this interaction, the project seeks to eliminate senescent cells and reduce fibrosis, offering potential for a curative treatment.
Pulmonary fibrosis is an age-related disease characterized by progressive scarring of lung tissue, loss of respiratory function, and premature death.
It is a fatal disease, affecting roughly ~5 million worldwide and causing >17.000 annual deaths in Europe alone.
There is no cure for pulmonary fibrosis, as current treatments modestly slow disease progression but do not reverse fibrosis or substantially improve survival.
These therapies often carry significant side effects and fail to address the…
WEIZMANN INSTITUTE OF SCIENCE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
